rs121908337
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_007078.3(LDB3):c.617C>T(p.Thr206Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000311 in 1,609,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000027 ( 0 hom. )
Consequence
LDB3
NM_007078.3 missense
NM_007078.3 missense
Scores
3
10
6
Clinical Significance
Conservation
PhyloP100: 4.62
Genes affected
LDB3 (HGNC:15710): (LIM domain binding 3) This gene encodes a PDZ domain-containing protein. PDZ motifs are modular protein-protein interaction domains consisting of 80-120 amino acid residues. PDZ domain-containing proteins interact with each other in cytoskeletal assembly or with other proteins involved in targeting and clustering of membrane proteins. The protein encoded by this gene interacts with alpha-actinin-2 through its N-terminal PDZ domain and with protein kinase C via its C-terminal LIM domains. The LIM domain is a cysteine-rich motif defined by 50-60 amino acids containing two zinc-binding modules. This protein also interacts with all three members of the myozenin family. Mutations in this gene have been associated with myofibrillar myopathy and dilated cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been identified; all isoforms have N-terminal PDZ domains while only longer isoforms (1, 2 and 5) have C-terminal LIM domains. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.801
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDB3 | NM_007078.3 | c.617C>T | p.Thr206Ile | missense_variant | 5/14 | ENST00000361373.9 | NP_009009.1 | |
LDB3 | NM_001368067.1 | c.321+1574C>T | intron_variant | ENST00000263066.11 | NP_001354996.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDB3 | ENST00000361373.9 | c.617C>T | p.Thr206Ile | missense_variant | 5/14 | 1 | NM_007078.3 | ENSP00000355296 | P4 | |
LDB3 | ENST00000263066.11 | c.321+1574C>T | intron_variant | 1 | NM_001368067.1 | ENSP00000263066 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
1
AN:
152220
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248358Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134358
GnomAD3 exomes
AF:
AC:
4
AN:
248358
Hom.:
AF XY:
AC XY:
3
AN XY:
134358
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1456924Hom.: 0 Cov.: 32 AF XY: 0.00000414 AC XY: 3AN XY: 724092
GnomAD4 exome
AF:
AC:
4
AN:
1456924
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
724092
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74358
GnomAD4 genome
AF:
AC:
1
AN:
152220
Hom.:
Cov.:
34
AF XY:
AC XY:
1
AN XY:
74358
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Dilated cardiomyopathy 1C Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 03, 2003 | - - |
Myofibrillar myopathy 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | The LDB3 gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_007078.3, and corresponds to NM_001080116.1:c.321+1574C>T in the primary transcript. This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 206 of the LDB3 protein (p.Thr206Ile). This variant is present in population databases (rs121908337, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of LDB3-related conditions and/or dilated cardiomyopathy (PMID: 14662268; Invitae). This variant is also known as T213I. ClinVar contains an entry for this variant (Variation ID: 4732). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this missense change affects LDB3 function (PMID: 19377068). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2019 | The p.T206I variant (also known as c.617C>T), located in coding exon 4 of the LDB3 gene, results from a C to T substitution at nucleotide position 617. The threonine at codon 206 is replaced by isoleucine, an amino acid with similar properties. In one study, this variant (also referred to as p.T213I, c.638C>T) was detected in a pediatric proband reported to have dilated cardiomyopathy (DCM), noncompaction, and conduction disease that improved on follow up to mild DCM. The parents were reportedly unaffected and did not have the variant. It is unclear if other genes associated with cardiomyopathy were analyzed in the proband (Vatta M et al. J. Am. Coll. Cardiol., 2003 Dec;42:2014-27). Functional studies suggest this variant may have some impact on protein function, but the clinical relevance is unclear (Arimura T et al. Cardiovasc. Res., 2009 Jul;83:80-8; Lin C et al. J. Biol. Chem., 2013 Oct;288:29403-13). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;.;T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D;D;D;D
M_CAP
Benign
T
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;.;M;M
MutationTaster
Benign
A;A;A;A;A;A;A;A;A;A
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;D;.;N
REVEL
Benign
Sift
Benign
T;.;D;T;.;T
Sift4G
Uncertain
D;D;T;D;T;D
Polyphen
0.94, 0.95, 0.96
.;.;P;.;P;D
Vest4
MutPred
Loss of phosphorylation at T206 (P = 0.0233);Loss of phosphorylation at T206 (P = 0.0233);Loss of phosphorylation at T206 (P = 0.0233);Loss of phosphorylation at T206 (P = 0.0233);Loss of phosphorylation at T206 (P = 0.0233);Loss of phosphorylation at T206 (P = 0.0233);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at